8-K: Marchex Q1 2026 Results: AI Focus and Archenia Acquisition Update

Marchex reported Q1 2026 results with a narrowed net loss and improved Adjusted EBITDA, driven by AI integration and progress on the Archenia acquisition.

Summary

• Marchex reported Q1 2026 GAAP revenue of $10.6 million, a decrease from $11.4 million in Q1 2025.
• The net loss for Q1 2026 was $1.7 million ($0.04 per diluted share), an improvement from a $2.0 million net loss ($0.05 per diluted share) in Q1 2025.
• Adjusted EBITDA for Q1 2026 was a loss of $0.1 million, an improvement from a loss of $0.8 million in Q1 2025.
• Excluding $0.7 million in reorganization and acquisition-related costs, Adjusted EBITDA for Q1 2026 would have been a gain of $0.6 million.
• Adjusted non-GAAP loss per share improved to $(0.03) in Q1 2026 from $(0.04) in Q1 2025.
• The company is progressing with the proposed acquisition of Archenia, Inc., with an expected closing in July 2026, subject to stockholder approval.
• Joint product development with Archenia is underway, focusing on AI-verified outcomes and Conversational AI Agents.
• Marchex anticipates sequential revenue increases in Q2 2026 and improved Adjusted EBITDA, projected between $1.6 to $1.8 million.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development due to improved financial metrics and a clear strategic direction with AI and the Archenia acquisition, despite a slight revenue dip in the current quarter.

Positives

• Narrowed net loss to $1.7 million in Q1 2026 from $2.0 million in Q1 2025.
• Improved Adjusted EBITDA to a loss of $0.1 million in Q1 2026 from a loss of $0.8 million in Q1 2025.
• Excluding acquisition costs, Adjusted EBITDA for Q1 2026 was a gain of $0.6 million.
• Adjusted non-GAAP loss per share improved to $(0.03) in Q1 2026 from $(0.04) in Q1 2025.
• Positive outlook for Q2 2026 with anticipated sequential revenue increase and Adjusted EBITDA projected between $1.6 to $1.8 million.
• Positive outlook for Q3 2026 with anticipated sequential revenue acceleration and Adjusted EBITDA potentially reaching $2 million or more.
• Potential for combined company (Marchex + Archenia) to achieve Adjusted EBITDA of $2.5 million or more in Q3 2026, with an annualized run rate of $10 million or more.
• Anticipates potential revenue growth on a run rate basis of 10% from 2025 year-end levels by the end of 2026.

Negatives

• GAAP revenue decreased to $10.6 million in Q1 2026 from $11.4 million in Q1 2025.
• The company reported a net loss of $1.7 million in Q1 2026.
• Adjusted EBITDA for Q1 2026 was a loss of $0.1 million, although this includes $0.7 million in reorganization and acquisition related costs.
• The Archenia acquisition is subject to stockholder approval and other closing conditions, introducing uncertainty.

Risks

• The company operates in a rapidly evolving and dynamic industry with uncertainties.
• The success of the Archenia acquisition is subject to stockholder approval and other closing conditions.
• Forward-looking statements involve substantial risks and uncertainties, including product demand, order cancellations and delays, competition, changes in business strategy, and general economic conditions.
• The company undertakes no duty to update forward-looking information provided in the release.

Future Outlook

Marchex anticipates sequential revenue increases in Q2 2026 and projects Adjusted EBITDA to be in the range of $1.6 to $1.8 million. For Q3 2026, revenue is expected to sequentially increase and potentially accelerate, with standalone Adjusted EBITDA potentially reaching $2 million or more. If the Archenia transaction closes by Q3 2026, the combined company could see Adjusted EBITDA in the $2.5 million range or more, with an annualized run rate of $10 million or more. The company expects quarterly revenue increases throughout 2026, potentially achieving a 10% revenue growth run rate from 2025 year-end levels, and Adjusted EBITDA margins of 10% or more.

Management Comments

• "We believe Marchex is a meaningful AI beneficiary based on how rapidly we are now able to leverage AI to develop and deploy new products into our customer base that can deliver high customer value and significant new company revenue opportunities."
• "In the first quarter of 2026, through our collaboration framework with Archenia, we continued developing and selling the initial key products that most leverage our strategic insights into AI-based action and outcome solutions, which have seen very encouraging initial adoption within our existing customer base."
• "While we operate in a rapidly evolving and dynamic industry with uncertainties, our sales efforts and customer interactions to date continue to reinforce our belief that we are now in a strong position with our ability to leverage new AI-based capabilities across the customer acquisition and optimization journey with highly impactful insight, action and outcome-based solutions."

Industry Context

StockSavvy.ai notes that Marchex's focus on AI and conversation intelligence aligns with a broader industry trend towards leveraging artificial intelligence for customer acquisition and optimization. The proposed acquisition of Archenia, a performance-based customer qualification company, further solidifies this strategic direction, aiming to create a vertically focused, AI-driven platform for customer acquisition and outcome optimization.

Comparison to Industry Standards

• The industry is rapidly moving towards Pay-Per-Event models, which Marchex's combined capabilities with Archenia are designed to address.
• Marchex's top 100 customers, representing 90% of revenue, are the initial focus for adopting new AI-driven products, indicating a concentrated customer strategy common in specialized software markets.
• The projected Adjusted EBITDA margins of 10% or more for 2026, especially post-acquisition, would position Marchex competitively within the AI and analytics software sector, though specific peer comparisons are not provided in the filing.

Corporate Governance

Related Party Transactions

• The acquisition of Archenia involves certain sellers who are related parties, necessitating review by a special committee of independent directors.

Stakeholder Impact

• Shareholders: Potential for increased value through the Archenia acquisition and AI-driven growth, but also subject to risks associated with the transaction and market dynamics.
• Employees: Continued focus on AI development and integration may lead to new opportunities and evolving roles.
• Customers: Introduction of new AI-powered solutions (AI-verified outcomes, Conversational AI Agents) aimed at increasing revenue and improving customer acquisition and optimization.
• Suppliers/Creditors: No direct impact mentioned, but financial performance improvements could strengthen the company's creditworthiness.

Next Steps

• Obtain approval of the Archenia transaction by a majority of Marchex's disinterested stockholders.
• Satisfy other closing conditions for the Archenia transaction.
• Close the Archenia acquisition, expected in July 2026.
• Continue developing and selling AI-verified outcomes and Conversational AI Agents.
• Focus on selling bundled solutions to the installed customer base.
• Achieve sequential revenue increases in Q2 and Q3 2026.
• Achieve projected Adjusted EBITDA targets for Q2, Q3, and beyond.

Key Dates

Recommendation

The company shows signs of operational improvement and a clear strategic pivot towards AI, with the Archenia acquisition poised to accelerate growth. However, the revenue decline in Q1 2026 and the inherent risks associated with the acquisition and the dynamic industry warrant a cautious 'hold' until the acquisition closes and its impact on revenue and profitability becomes clearer.

Keywords

Marchex, AI, Conversation Intelligence, Archenia, Acquisition, Earnings, Financial Results, Q1 2026